IPS/Pluripotent Stem Cell hUMAN dATA HAS ARRived
BioSpace
The New York Times
Patients no longer needed daily insulin shots with a single Vertex iPS injection.
The New York Times
The New York Times
Reports of restored functional benefit in diabetic patients by creating new insulin producing beta cells.
The Lancet
Restored eyesight in over half of patients by creating new retinal pigment epithelium.
JACC Journals
Restored heart function as pluripotent derived cardiac progenitor cells (CPCs) by IPS HEART Advisor Dr. Menasche in his Phase I clinical trial in Paris increased left ventricular ejection fraction (LVEF) from 26% to 38% after three months with no safety issues.
The Wall Street Journal
The Wall Street Journal
Scientists are reverse-engineering patients’ own skin or blood cells to behave similarly to embryonic cells and using them in tests to treat incurable diseases.